Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PCRX
#2101
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-5.88%
Changement Mensuel
+10.54%
Evolution sur 6 mois
+0.37%
Changement Annuel
+0.37%
Clôture Précédente
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volume
171
Marchés
Actions des Marchés US
Soins de Santé
PCRX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
46.17 M
46.28 M
46.3 M
44.93 M
43.02 M
40.49 M
—
Valuation ratios
Enterprise value
448.94 M
595.07 M
867.06 M
773.41 M
961.07 M
889.33 M
3.49 B
Price to earnings ratio
-7.72
-8.76
-11.09
-8.72
52.59
161.75
194.53
Price to sales ratio
1.09
119.65
2.3
2.12
2.21
—
—
Price to cash flow ratio
3.69
4.6
6.71
8.21
8.28
7.67
30.88
Price to book ratio
0.22
1.12
0.37
0.36
0.38
1.68
2.79
Enterprise value to EBITDA ratio
11.94
-1.67
-2.17
-1.88
-3.67
—
—
Profitability ratios
Return on assets %
0.06
0.01
0
-0
-0
-0.01
-0.01
Return on equity %
0.12
0.02
0.01
-0.01
-0.01
-0.01
-0.02
Return on invested capital %
19.89
10.31
0.43
-1.72
1.48
0.68
0.87
Gross margin %
76.95
21.9 K
79.69
77.43
80.91
79.53
317.56
Operating margin %
33.59
-13.5 K
1.18
4.69
3.54
1.19
10.6
EBITDA margin %
-72.67
192.01 K
15.42
19.59
15.4
-27.24
23.17
Net margin %
52.05
-8 765.57
2.85
-2.64
-2.37
-4.09
-6.26
Liquidity ratios
Quick ratio
1.89
2
1.99
1.91
3.78
3.28
10.96
Current ratio
2.25
2.4
2.41
2.38
5.26
4.54
14.6
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.11
-0
0.11
0.12
0.13
0.15
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.25
0.24
0.25
0.29
0.29
1.07
Long term debt to total equity ratio
0.51
0.49
0.48
0.5
0.52
0.54
2.03
Per share metrics
Operating cash flow per share
1.17
0.72
0.76
0.26
1.33
0.97
3.32
EBIT per share
-3.09
-8.06
0.11
0.18
0.14
-1.66
-1.24
EBITDA per share
-2.65
-7.6
0.56
0.77
0.6
-1.19
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.81
10.48
10.61
9.72
5.39
5.29
31.01
Net current asset value per share
14.91
16.11
16.33
16.26
12.31
12.17
57.06
Tangible book value per share
6.68
7.62
7.35
6.87
7.1
6.77
28.08
Working capital per share
8.29
9.41
9.57
9.43
9.96
9.49
38.45
Book value per share
16.2
16.83
17.16
16.52
15.9
15.39
64.98
Nouvelles
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Le BPA de Pacira a manqué les attentes de 0,33$, le CA en dessous des prévisions
Pacira publie ses résultats alors qu’EXPAREL fait face aux génériques
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
La SVP de Pacira BioSciences, Lauren Riker, vend des actions pour 83k€
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Le dirigeant de Pacira BioSciences vend des actions pour 269.702€
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Pacira BioSciences nomme Samit Hirawat à son conseil d’administration
Pacira BioSciences appoints Samit Hirawat to board of directors